Dotmatics
1 known investors
Find your way into Dotmatics
Sign up to see every warm intro you have to Dotmatics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dotmatics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dotmatics provides a scientific research informatics platform for biologics drug discovery, offering end-to-end data management and analysis across therapeutics such as antibodies, CAR-T cells, and RNA therapeutics. Its biology solution covers workflows including molecular cloning, vector design, protein production, biologics registration, assays, and results analysis for research scientists and R&D organizations.
Investors · 1
Frequently asked questions
- What does Dotmatics do?
- Dotmatics provides a scientific research informatics platform for biologics drug discovery, offering end-to-end data management and analysis across therapeutics such as antibodies, CAR-T cells, and RNA therapeutics. Its biology solution covers workflows including molecular cloning, vector design, protein production, biologics registration, assays, and results analysis for research scientists and R&D organizations.
- Who are Dotmatics's investors?
- Dotmatics's investors include Scottish Equity Partners.
